1. Tichacek, C.J., Budzevich, M.M., Wadas, T.J., Morse, D.L., Moros, E.G. “A Monte Carlo Method for Determining the Response Relationship between Two Commonly Used Detectors to Indirectly Measure Alpha Particle Radiation Activity.” Molecules. 2019; 24(18); E3397. doi: 10.3390/molecules24183397. PMID: 31546752.
     
  2. Tafreshi, N.K., Tichacek, C.J., Pandya, D.N., Doligalsk,i M.L., Budzevich, M.M., Kil, H., Bhatt, N.B., Kock, N.D., Messina, J.L., Ruiz, E.E., Delva, N.C., Weaver, A., Gibbons, W.R., Boulware, D.C., Khushalani, N.I., El-Haddad, G, Triozzi, P.L., Moros, E.G., McLaughlin, M.L., Wadas, T.J., Morse, D.L. “Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.” J Nucl Med. 2019; 60(8):1124-1133. PMID: 30733316.
     
  3. Pandya, D.N., Bhatt, N.B., Almaguel, F., Rideout-Danner, S., Gage, H.D., Sai, K.K.S, Wadas, T.J. “Zirconium-89 chloride can be used for immuno-PET radiochemistry without loss of antigen reactivity in vivo.“ J Nucl Med. 2019; 60(5): 696-701. PMID: 30442753.
     
  4. Bhatt, N.B., Pandya, D.N., Rideout-Danner S., Gage, H.D., Marini, F.C., Wadas, T.J. “A Comprehensively Revised Strategy that Improves the Specific Activity and Long-term Stability of Clinically Relevant 89Zr-immuno-PET Agents.” Dalton Trans. 2018; 47(37): 13214-13221. PMID: 30178793.
     
  5. Sattiraju, A., Xiong, X., Pandya, D.N., Wadas, T.J., Xuan, A., Sun, Y., Jung, Y., Solingapuram, Sai K.K., Dorsey, J.F., Li, K.C., Mintz, A. “Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3 Targeted Liposomes.” Mol Cancer Ther. 2017; 16(10):2191-2200. PMID: 28619756.
     
  6. Bhatt, N.B., Pandya, D.N., Xu, J., Tatum, D., Magda, D., Wadas, T.J. “Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89.” PLoS One. 2017; 12(6): e0178767. PMID: 28575044.
     
  7. Sattiraju, A., Solingapuram, Sai K.K., Xuan, A., Pandya, D.N., Almaguel, F.G., Wadas, T.J., Herpai, D.M., Debinski, W., Mintz, A. “IL13RA2 Targeted Alpha Particle Therapy Against Glioblastomas.” Oncotarget. 2017; 8(26): 42997-43007. PMID: 28562337.
     
  8. Pandya, D.N., Bhatt, N., Yuan, H., Day, C.S., Ehrmann, B.M., Wright, M., Bierbach, U., Wadas,T.J. “Zirconium Tetraazamacrocycle Complexes Display Extraordinary Stability and Provide a New Strategy for Zirconium-89-Based Radiopharmaceutical Development.” Chem Sci. 2017; 8(3): 2309-2314. PMID: 28451334.
     
  9. Xiong, X., Pandya, D.N., Jung, Y., Mintz, A., Hayasaka, S., Wadas, T.J., Li, K., Sun, Y. “Enhancing Tissue Permeability with MRI Guided Preclinical Focused Ultrasound System in Rabbit Muscle: From Normal Tissue to VX2 Tumor.” J Control Release. 2017; 256: 1-8. Epub 2017 PMID: 28412225.
     
  10. Tichacek, C.J., Tafreshi, N.K., Budzevich, M.M., Ruiz, E., Wadas, T.J., McLaughlin, M.L., Moros, E.G. and L. Morse, D. "WE‐FG‐BRA‐10: Radiodosimetry of a Novel Alpha Particle Therapy Targeted to Uveal Melanoma: Absorbed Dose to Organs in Mice." Med Phys. 2016; 43: 3825-3826. doi:10.1118/1.4957910
     
  11. Pandya, D.N., Hantgan, R., Budzevich, M.M., Kock, N.D., Morse, D.L., Batista, I., Mintz, A., Li, K.C., Wadas, T.J. “Preliminary Therapy Evaluation of 225Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from 225Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization” Theranostics. 2016; 6(5); 698-709. doi:10.7150/thno.14338.
     
  12. Tinianow, J.N., Pandya, D.N., Pailloux, S.L., Ogasawara, A., Vanderbilt, A.N., Gill, H.S., Williams, S.P., Wadas, T.J., Magda, D., Marik, J. “Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for 89Zr4+ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.” Theranostics. 2016; 6(4); 511-521. doi:10.7150/thno.14261.
     
  13. Pandya, D.N., Pailloux, S., Tatum, D., Magda, D., Wadas, T.J. “Di-macrocyclic Terepthalamide Ligands as Chelators for the PET Radionuclide Zirconium-89.” Chem Comm. 2015; 52(12); 2301-2303. PMID: 25556851.
Invited Publications
  1. Tafreshi, N.K., Doligalsk,i M.L., Tichacek, C.J., Pandya, D.N., Budzevich, M.M., El-Haddad, G., Khushalani, N.I., Moros, E.G., McLaughlin, M.L., Wadas, T.J., Morse, D.L. “Development of Targeted Alpha Particle Therapy for Solid Tumors.” Molecules. 2019;24(23). pii: E4314. doi: 10.3390/molecules24234314. PMID: 31779154.
     
  2. Bhatt, N.B., Pandya, D.N., Wadas, TJ. “Recent Advances in Zirconium-89 Chelator Development.” Molecules. 2018; 23(3), 638-662. PMID: 29534538.
     
  3. Bhatt, N.B., Pandya, D.N., Dezarn, W.A., Marini, F.C., Zhao, D., Gmeiner, W.H., Triozzi, P.L., Wadas, TJ. “Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes.” Methods Mol Biol. 2018; 1790:197-208. PMID: 29858793.
     
  4. Wadas, T.J., Pandya, D., Solingapuram, K.K.S., Mintz, A. “Molecular Targeted α-Particle Therapy for Oncologic Applications” AJR Am J Roentgenol. 2014; 203(2); 253-260. PMID: 25055256.